Anders Jack's Form 4 filing
Revolution Medicines, Inc.RVMD · filed Sep 18, 2026
- Accession no.
- 0001800668-26-000007
- Filed
- Sep 18, 2026, 6:00 PM ET
- Trade date
- Sep 16, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $807.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Anders JackCIK 0001800668 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Common Stock | SSaleDisposed | −61 | $195.00 | −$11,895 | 123,208 | Direct | |
| Sep 16, 2026 | Common Stock | SSaleDisposed | −3,992 | $199.30 | −$795,618.37 | 119,216 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.